Skip to main content

Advertisement

SpringerLink
Log in

Investigation of the common paraoxonase 1 variants with paraoxonase activity on bone fragility in Turkish patients

  • Published:
Molecular Biology Reports Aims and scope Submit manuscript

Abstract

There is increasing evidence of a biochemical link between oxidative stress and bone metabolism. Oxidative stress has been shown to be involved in bone resorption as it causes loss of bone mineral density (BMD). Paraoxonase 1 (PON1), can prevent these effects of the oxidative stress on bone formation. It has been suggested that the PON1 gene as possibly implicated in reduced BMD in bone fragility cases. It has been hypothesized that PON1 gene polymorphisms may influence both the risk of osteoporosis and osteopenia occurrence and prognosis. The aim of our study is to evaluate the relationship between PON1 polymorphisms and bone fragility development. Seventy-four osteoporotic, 121 osteopenic and 79 nonosteoporotic postmenopausal women were recruited. For detection of the polymorphisms, polymerase chain reaction-restriction fragment length polymorphism techniques have been used. BMD was measured at the lumbar spine and hip by dual-energy X-ray absorptiometry. Distributions of PON1 (PON 192 and PON 55) polymorphisms in study groups were not significantly different. But, there was medium strength connection between in the osteopenic with control groups regarding PON1 55–PON1 192 haplotypes and we found a power strength connection between in the osteoporosis with control groups regarding PON1 55–PON1 192 haplotypes. Furthermore, subjects with PON1 192RR and PON1 55LL genotypes had lower PON activity values of osteoporotic subject compared to healthy control and this difference was statistically significant (p < 0.05). This result suggest that PON1 genotypes could be higher risk for osteoporosis, as determined by reduced BMD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Huang QY, Kung AW (2006) Genetics of osteoporosis. Mol Genet Metab 88:295–306

    Article  PubMed  CAS  Google Scholar 

  2. Yamada Y, Ando F, Niino N, Miki T, Shimokata H (2003) Association of polymorphisms of paraoxonase 1 and 2 genes, alone or in combination, with bone mineral density in community- dwelling Japanese. J Hum Genet 48:469–475

    Article  PubMed  CAS  Google Scholar 

  3. Lorenc RS, Misiorowski W, Karczmarewicz E (2009) Critical points in strategies for the diagnosis and treatment of osteoporosis. Endokrynol Pol 60:124–133

    PubMed  Google Scholar 

  4. Siris ES, Miller PD, Barrett-Connor E, Faulkner KG, Wehren LE, Abbott TA, Berger ML, Santora AC, Sherwood LM (2001) Identification and fracture outcomes of undiagnosed low bone mineral density in postmenopausal women: results from the National Osteoporosis Risk Assessment. JAMA 286:2815–2822

    Article  PubMed  CAS  Google Scholar 

  5. Shan LP, Bee OF, Suniza SS, Adeeb N (2011) Developing a Malaysian Osteoporosis Screening Tool (MOST) for early osteoporosis detection in Malaysian women. Sex Reprod Healthc 2:77–82

    Article  PubMed  Google Scholar 

  6. Andrew T, Antioniades L, Scurrah KJ, MacGregor AJ, Spector TD (2005) The risk of wrist fracture in women is heritable and is influenced by genes that are largely independent of those influencing bone mineral density. J Bone Miner Res 20:67–74

    Article  PubMed  Google Scholar 

  7. Deng HW, Mahaney MC, Williams JT, Li J, Conway T, Davies KM, Li JL, Deng H, Recker RR (2002) Relevance of the genes for bone mass variation to susceptibility to osteoporotic fractures and its implications to gene search for complex human diseases. Gene Epidemiol 22:12–25

    Article  Google Scholar 

  8. Massart F, Reginster JY, Brandi ML (2001) Genetics of menopause-associated diseases. Maturitas 40:103–116

    Article  PubMed  CAS  Google Scholar 

  9. Huang QY, Recker RR, Deng HW (2003) Searching for osteoporosis genes in the post-genome era: progress and challenges. Osteoporos Int 14:701–715

    Article  PubMed  Google Scholar 

  10. Clarke B (2008) Normal bone anatomy and physiology. Clin J Am Soc Nephrol 3:131–139

    Article  Google Scholar 

  11. Costa LG, Vitalone A, Cole TB, Furlong CE (2005) Modulation of paraoxonase (PON1) activity. Biochem Pharmacol 69:541–550

    Article  PubMed  CAS  Google Scholar 

  12. Almeida M, Ambrogini E, Han L, Manolagas SC, Jilka RL (2009) Increased lipid oxidation causes oxidative stress, increased peroxisome proliferator-activated receptor-gamma expression, and diminished pro-osteogenic Wnt signaling in the skeleton. J Biol Chem 284:27438–27448

    Article  PubMed  CAS  Google Scholar 

  13. Parhami F, Jackson SM, Tintut Y, Le V, Balucan JP, Territo M, Demer LL (1999) Atherogenic diet and minimally oxidized low density lipoprotein inhibit osteogenic and promote adipogenic differentiation of marrow stromal cells. J Bone Miner Res 14:2067–2078

    Article  PubMed  CAS  Google Scholar 

  14. Mackinnon ES, El-Sohemy A, Rao AV, Rao LG (2010) Paraoxonase 1 polymorphisms 172T/A and 584A/G modify the association between serum concentrations of the antioxidant lycopene and bone turnover markers and oxidative stress parameters in women 25-70 years of age. J Nutrigenet Nutrigenomics 3:1–8

    Article  PubMed  CAS  Google Scholar 

  15. Deakin SP, James RW (2004) Genetic and environmental factors modulating serum concentrations and activities of the antioxidant enzyme paraoxonase-1. Clin Sci (Lond) 107:435–447

    Article  CAS  Google Scholar 

  16. Eren Z, Kantarci G, Biyikli N, Arikan H, Tuglular S, Ergen A, Isbir T, Akoglu E (2012) Paraoxonase 1 polymorphisms in patients with primary glomerulonephritis: a single-center study in Turkey. Iran J Kidney Dis 6:181–185

    PubMed  Google Scholar 

  17. Sztanek F, Seres I, Harangi M, Locsey L, Padra J, Paragh GJ, Asztalos L, Paragh G (2012) Decreased paraoxonase 1 (PON1) lactonase activity in hemodialyzed and renal transplanted patients. A novel cardiovascular biomarker in end-stage renal disease. Nephrol Dial Transplant 27:2866–2872

    Article  PubMed  CAS  Google Scholar 

  18. Harel M, Aharoni A, Gaidukov L, Brumshtein B, Khersonsky O, Meged R, Dvir H, Ravelli RB, McCarthy A, Toker L, Silman I, Sussman JL, Tawfik DS (2004) Structure and evolution of the serum paraoxonase family of detoxifying and anti-atherosclerotic enzymes. Nat Struct Mol Biol 11:412–419

    Article  PubMed  CAS  Google Scholar 

  19. Billecke S, Draganov D, Counsell R, Stetson P, Watson C, Hsu C, La Du BN (2000) Human serum paraoxonase (PON1) isozymes Q and R hydrolyze lactones and cyclic carbonate esters. Drug Metab Dispos 28:1335–1342

    PubMed  CAS  Google Scholar 

  20. Furlong CE, Richter RJ, Seidel SL, Costa LG, Motulsky AG (1989) Spectrophotometric assay for the enzymatic hydrolysis of the active metabolites of chlorpyrifos and parathion by plasma paraoxonase/arylesterase. Anal Biochem 180:242–247

    Article  PubMed  CAS  Google Scholar 

  21. Miller SA, Dykes DD, Polesky HS (1988) Simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acid Res 16:1215

    Article  PubMed  CAS  Google Scholar 

  22. Humbert R, Adler DA, Disteche CM, Hassett C, Omiecinski CJ, Furlong CE (1993) The molecular basis of the human serum paraoxonase activity polymorphism. Nature Genet 3:73–76

    Article  PubMed  CAS  Google Scholar 

  23. Adkins S, Gan KN, Mody M, La Du BN (1993) Molecular basis for the polymorphic forms of human serum paraoxonase/arylesterase glutamine or arginine at position 191, for the respective A or B allozymes. Am J Hum Genet 52:598–608

    PubMed  CAS  Google Scholar 

  24. Mackness B, Mackness MI, Arrol S, Turkie W, Durrington PN (1998) Effect of the human serum paraoxonase 55 and 192 genetic polymorphisms on the protection by high density lipoprotein against low density lipoprotein oxidative modification. FEBS Lett 423:57–60

    Article  PubMed  CAS  Google Scholar 

  25. Davies HG, Richter RJ, Keifer M, Broomfield CA, Sowalla J, Furlong CE (1996) The effect of the human serum paraoxonase polymorphism is reversed with diazoxon, soman and sarin. Nat Genet 14:334–336

    Article  PubMed  CAS  Google Scholar 

  26. Li WF, Costa LG, Richter RJ, Hagen T, Shih DM, Tward A, Lusis AJ, Furlong CE (2000) Catalytic efficiency determines the in vivo efficacy of PON1 for detoxifying organophosphorus compounds. Pharmacogenetics 10:767–779

    Article  PubMed  CAS  Google Scholar 

  27. Garin MC, James RW, Dussoix P, Blanche H, Passa P, Froguel P, Ruiz J (1997) Paraoxonase polymorphism Met-Leu54 is associated with modified serum concentrations of the enzyme. A possible link between the paraoxonase gene and increased risk of cardiovascular disease in diabetes. J Clin Invest 99:62–66

    Article  PubMed  CAS  Google Scholar 

  28. Aviram M, Hardak E, Vaya J, Mahmood S, Milo S, Hoffman A, Billicke S, Draganov D, Rosenblat M (2000) Human serum paraoxonase (PON1) Q and R selectively decrease lipid peroxides in human coronary and carotid arteriosclerotic lesions. Circulation 101:2510–2517

    Article  PubMed  CAS  Google Scholar 

  29. McGrowder D, Riley C, Morrison EY, Gordon L (2011) The role of high-density lipoproteins in reducing the risk of vascular diseases, neurogenerative disorders, and cancer. Cholesterol 2011:496925

    Article  PubMed  Google Scholar 

  30. Kim BJ, Kim SY, Cho YS, Kim BJ, Han BG, Park EK, Lee SH, Kim HY, Kim GS, Lee JY, Koh JM (2011) Association of Paraoxonase 1 (PON1) polymorphisms with osteoporotic fracture risk in postmenopausal Korean women. Exp Mol Med 28(43):71–81

    Article  Google Scholar 

  31. Basu S, Michaelsson K, Olofsson H, Johansson S, Melhus H (2001) Association between oxidative stress and bone mineral density. Biochem Biophys Res Commun 288:275–279

    Article  PubMed  CAS  Google Scholar 

  32. Verit FF, Celik H, Yazgan P, Erel O, Geyikli I (2007) Paraoxonase-1 activity as a marker of atherosclerosis is not associated with low bone mineral density in healthy postmenopausal women. Arch Gynecol Obstet 275:35–353

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Molecular Medicine, The Institute of Experimental Medicine (DETAE), İstanbul University, Capa, 34390, Istanbul, Turkey

    Bahar Toptaş, Hülya Yılmaz Aydoğan, Ilhan Yaylim, Ümit Zeybek & Bedia Agachan

  2. Department of Biochemistry, Faculty of Pharmacy, Istanbul University, Istanbul, Turkey

    Özlem Kurt & Ayse Can

  3. Physical Therapy and Rehabilitation Clinic, Üsküdar State Hospital, Istanbul, Turkey

    Mehmet Uyar & M. Kerem Özyavuz

  4. Department of Medical Biology, Faculty of Medicine, Yeditepe University, Istanbul, Turkey

    Turgay İsbir

Authors
  1. Bahar Toptaş
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Özlem Kurt
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hülya Yılmaz Aydoğan
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ilhan Yaylim
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Ümit Zeybek
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Ayse Can
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Bedia Agachan
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Mehmet Uyar
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. M. Kerem Özyavuz
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Turgay İsbir
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ilhan Yaylim.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Toptaş, B., Kurt, Ö., Aydoğan, H.Y. et al. Investigation of the common paraoxonase 1 variants with paraoxonase activity on bone fragility in Turkish patients. Mol Biol Rep 40, 6519–6524 (2013). https://doi.org/10.1007/s11033-013-2770-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11033-013-2770-5

Keywords

Search

Navigation